Verhasselt et al., 2004 - Google Patents
Induction of FOXP3‐expressing regulatory CD4pos T cells by human mature autologous dendritic cellsVerhasselt et al., 2004
View PDF- Document ID
- 3773051506163576693
- Author
- Verhasselt V
- Vosters O
- Beuneu C
- Nicaise C
- Stordeur P
- Goldman M
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
Current literature suggests that T cells recognizing antigen on mature dendritic cells (DC) differentiate into effector T cells whereas tolerance is induced when antigen is presented by immature DC. We investigated the consequences of the interactions between immature or …
- 210000001744 T-Lymphocytes 0 title abstract description 145
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Verhasselt et al. | Induction of FOXP3‐expressing regulatory CD4pos T cells by human mature autologous dendritic cells | |
Yao et al. | Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy | |
Abramson et al. | Thymic epithelial cells | |
Dieckmann et al. | Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood | |
Xystrakis et al. | Reversing the defective induction of IL-10–secreting regulatory T cells in glucocorticoid-resistant asthma patients | |
Cavani et al. | Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses | |
Bisikirska et al. | TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+ CD25+ Tregs | |
Wang et al. | Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells | |
Hong et al. | Induction of CD4+ CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3 | |
Tarbell et al. | The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity | |
Correale et al. | Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis | |
Veerapathran et al. | Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly | |
AU2008201685B2 (en) | CD4+CD25+ regulatory T cells from human blood | |
Cavani et al. | Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells | |
Mailliard et al. | Complementary dendritic cell–activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses | |
EP1812563B1 (en) | Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use | |
Dong et al. | Multiparameter single-cell profiling of human CD4+ FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease | |
Adler et al. | Activation of MAP kinase p38 is critical for the cell-cycle–controlled suppressor function of regulatory T cells | |
Neerven et al. | Requirement of CD28‐CD86 costimulation for allergen‐specific T cell proliferation and cytokine expression | |
Alard et al. | Deficiency in NOD Antigen-Presenting Cell Function May Be Responsible for Suboptimal CD4+ CD25+ T-Cell–Mediated Regulation and Type 1 Diabetes Development in NOD Mice | |
Vogel et al. | Foxp3+ regulatory T cells are activated in spite of B7‐CD28 and CD40‐CD40L blockade | |
Larbi et al. | The immune system in the elderly: a fair fight against diseases? | |
Vlad et al. | CD8+ T suppressor cells and the ILT3 master switch | |
Maggi et al. | Dexamethasone and monophosphoryl lipid A-modulated dendritic cells promote antigen-specific tolerogenic properties on naive and memory CD4+ T cells | |
Lanzinger et al. | Ambivalent effects of dendritic cells displaying prostaglandin E 2‐induced indoleamine 2, 3‐dioxygenase |